Gastrointestinal pathology in a mouse model of mucopolysaccharidosis type IIIA

Ainslie L K Derrick Roberts1, Gordon S Howarth, Wan Chin Liaw

  • 1Department of Genetic Medicine, Matrix Biology Unit, Children, Youth and Women's Health Service, North Adelaide, SA, Australia.

Insights

Mucopolysaccharidosis type IIIA (MPS IIIA) in mice shows gastrointestinal changes, including increased stomach and duodenum size. These GI abnormalities may contribute to the increased body weight observed in MPS IIIA mice.

Area of Science:

  • Biochemistry
  • Genetics
  • Pathology

Background:

  • Mucopolysaccharidosis type IIIA (MPS IIIA) is a genetic lysosomal storage disorder.
  • It results from a deficiency in sulphamidase (NS), impairing heparan sulphate glycosaminoglycan (GAG) degradation.
  • MPS IIIA mouse models exhibit CNS pathology and GAG accumulation in tissues.

Purpose of the Study:

  • To characterize gastrointestinal (GI) morphology and function in the MPS IIIA mouse model.
  • To investigate potential links between GI abnormalities and weight gain in MPS IIIA.

Main Methods:

  • Comparative analysis of GI tract morphology in MPS IIIA and wild-type mice.
  • Assessment of gastric emptying rates for solid and liquid meals.
  • Measurement of sucrase enzyme activity in the GI tract.

Main Results:

  • MPS IIIA mice showed increased stomach and duodenum weight and length.
  • Increased submucosal thickness and GAG storage were observed in the MPS IIIA intestine.
  • Gastric emptying of solid meals was altered with age in MPS IIIA mice, and sucrase activity was elevated.

Conclusions:

  • MPS IIIA mice exhibit distinct GI structural and functional alterations.
  • These GI abnormalities are potential contributors to the characteristic weight gain in MPS IIIA.
  • The MPS IIIA mouse serves as a valuable model for studying GI manifestations of lysosomal storage disorders.

Related Concept Videos